16 result(s) for 'NanoString'
1 - 10 of 16 results for 'NanoString'
Accelerate Your Breakthrough Discoveries with Enhanced BOND RX & Nanostring GeoMx Automated RNA Digital Spatial Profiling
SEATTLE, USA and MELBOURNE, AUSTRALIA. March 1st Leica Biosystems continues to advance its relationship with NanoString Technologies Inc., supporting translational research to build confidence in reproducibility and throughput while minimizing manual steps and reducing hands-on time with the release of the fully automated GeoMx RNA protocol on BOND RX and BOND RXm research staining systems. “This fully automated protocol not only increased our ability to get more slides done in a week but also increased the quality of the data coming off of our instrument by reducing variability between runs,” said Carlee Hemphill, lead scientist, CDx Labcorp Drug Development. NanoString's GeoMx Digital Spatial Profiler uses spatial images, chemistry, and workflow to enable high-plex profiling ...
Bryan graduated from the University of Glasgow in Genetics back in 2000. Since then he has obtained a PhD from the Beatson Institute for Cancer Research and worked as post doc and research scientist for more than 10 years in academia before joining NanoString last year.
Dr. Mathias Holpert is working as a Sr. Product Application Scientist (EMEA) at NanoString. In this role, he is responsible for training users on the GeoMx Digital Spatial Profiler platform and for consultation and support of customer projects. He received a Diploma in Biology from the university of Würzburg, Germany and a Doctors degree (Dr. rer. nat.) from the university of Göttingen, Germany.
Alistaire Ruggiero-Sherman is a biomedical scientist with expertise in aging biology and cardiometabolic diseases. She received her Ph.D. in Molecular Medicine and Translational science from Wake Forest University School of Medicine. In 2021, she received the National Institutes of Health Immunology and Pathogenesis Training Award for her work investigating peripheral tissue dysfunction with metabolic disease onset. Her postdoctoral studies evaluated aging biomarkers in circulation for clinical application. Alistaire is the Field Application Scientist for NanoString Technologies and focuses on bulk genomic and spatial biology experiment design and data analysis.
Espy Anguiano, PhD, is the Scientific Market Development Director for BioPharma at NanoString Technologies. Espy is focused on the successful adoption of spatial technologies in drug development research activities. Espy supports NanoString Technologies' global pharmaceutical and CRO customers representing an install base of over 70 GeoMx Digital Spatial Profiler and 20 CosMx Spatial Molecular Imager platforms across the globe. Espy obtained her PhD in Biomedical Science from Baylor University and holds a dual business degree (MS-MBA) from Temple University. She has over 20 years of experience in molecular biology and genomics research and is passionate about harnessing innovative technologies and science to understand human disease and advance drug development. Espy played a l...
Gen Yong is a FAS with Nanostring Technologies. He previously did his PhD at UCSD in the field of bioengineering working on drug delivery vehicles and oncolytic viruses, and had a stint at OHSU managing a spatial center of excellence prior to joining Nanostring. In his free time, Gen like to go around taking pictures with random llamas and is lucky to have all his ears, nose and fingers intact.
Nick Confuorto is a Senior Director Global Field Applications at Nanostring Technologies where he is responsible for leading the development and execution of the strategic plan for the GeoMx Digital Spatial Profiling (DSP) business unit. Prior to joining Nanostring, Nick held several commercial roles across the Life Sciences industry with experience in bringing to market new capabilities in the Imaging, Flow Cytometry, and Mass Spectrometry fields. Nick has a strong passion for introducing cutting edge technologies that can accelerate Translational Research with the ultimate promise of benefiting patient care through precision medicine.